Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

BioNTech SE - American Depositary Shares (NQ:BNTX)

87.53 -3.17 (-3.50%)
Delayed Quote Updated: 11:13 AM EST, Nov 5, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about BioNTech SE - American Depositary Shares

< Previous 1 2
...
24 25 26 27 28 29 30 31 32
...
74 75 Next >
News headline image
The 3 Most Undervalued Growth Stocks for Your February Buy List ↗
These undervalued growth stocks have the value and projected growth that investors seek when researching their next investment decisions. 
Via InvestorPlace
News headline image
Better Buy: Novavax or BioNTech Stock? ↗
The two companies, known for their vaccines, could see their businesses benefit from a yearly COVID-19 shot. 
Via The Motley Fool
News headline image
The 7 Most Undervalued Biotech Stocks to Buy in February 2023 ↗
Get your hands on the latest medical innovations at a compelling discount with the most undervalued biotech stocks to buy. 
Via InvestorPlace
News headline image
BioNTech Strengthens Manufacturing Capabilities with First In-House Plasmid DNA Manufacturing Facility
From BioNTech SE
Via GlobeNewswire
Analyst Ratings for BioNTech ↗
 
Via Benzinga
News headline image
Novavax Shares Jumped in January While Others Slipped
Updated FDA Covid vaccine policy could've boosted NVAX shares at the end of January, when other pharma stocks slipped, but it may not affect the bottom line. 
Via MarketBeat
News headline image
Why BioNTech And Moderna Shares Are Falling After Pfizer News ↗
BioNTech SE - ADR (NASDAQ: BNTX) and Moderna Inc (NASDAQ: MRNA) shares are trading lower Tuesday morning in sympathy with Pfizer Inc. (NYSE: 
Via Benzinga
News headline image
$1,000 Invested In 4 Of The 5 Vaccine Developers Back When WHO Declared COVID-19 An Emergency Yielded Returns ↗
The COVID-19 pandemic emerged in 2019 in China and spread to the rest of the globe in early 2020. Since then, the virus has caused more than 6.8 million deaths. 
Via Benzinga
News headline image
Novavax Jumps After Pledging To Update Its Covid Shot; Pfizer, Moderna Slip ↗
The FDA's experts voted in favor of annual boosters on Thursday. 
Via Investor's Business Daily
News headline image
Mergers and Acquisitions in 2023 Off To A Strong Start
Mergers and acquisitions are common, especially across the health sector. Here are some lesser-known buyouts and how they could fare down the road. 
Via MarketBeat
News headline image
Thursday Predictions: 3 Hot Stocks for Tomorrow ↗
Airline stocks, credit card stocks, and vaccine stocks are our focus when it comes to the hot stocks for tomorrow. Here's why. 
Via InvestorPlace
News headline image
COVID-19 Vaccine Strategy Might Follow The Influenza Shot Way, FDA To Decide Today ↗
The FDA is considering a significant shift in the U.S.'s COVID-19 vaccine strategy to simplify vaccination against COVID-19. 
Via Benzinga
News headline image
Google Layoffs 12K Employees, Netflix's Q4 Earnings And CEO Steps Down, FDA Rejects Eli Lilly's Alzheimer's Candidate: Top Stories Friday, Jan. 20 ↗
Here's a round-up of stories from around the globe and from various media outlets. Benzinga 
Via Benzinga
News headline image
Israel Says No Stroke Risk Associated With Pfizer/BioNTech Updated COVID-19 Shots ↗
Israel health ministry official said Isreal had not identified any evidence linking strokes to an updated coronavirus vaccine by Pfizer Inc (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX). 
Via Benzinga
News headline image
Pfizer (PFE) Stock Falls on Analyst Downgrade ↗
Although Pfizer led the charge in forwarding Covid-19 solutions, possibly waning relevancy poses serious concerns for PFE stock. 
Via InvestorPlace
News headline image
Pfizer Stock Dives As Analyst Calls For 'Covid Reset' And Downgrades Shares ↗
Shares have skidded almost 10% in the first two weeks of 2023. 
Via Investor's Business Daily
News headline image
US Health Agencies Investigate Preliminary COVID-19 Vaccine Safety Signal In Older People ↗
The U.S. 
Via Benzinga
News headline image
Johnson & Johnson Cuts Production, Ends Contracts For Not So Successful COVID-19 Shot ↗
Johnson & Johnson (NYSE: JNJ) has significantly scaled back its efforts of manufacturing its COVID-19 vaccine after facing a fall in demand. 
Via Benzinga
News headline image
Nice Gains During JPM23 Week: Benign CPI Report Brings Hope For A “Soft Landing” ↗
Small-cap speculative biotech stocks regain interest with volatility. 
Via Talk Markets
News headline image
BioNTech Strengthens Its Artificial Intelligence With Acquisition Of British Startup ↗
 
Via Benzinga
News headline image
BioNTech to Acquire InstaDeep to Strengthen Pioneering Position in the Field of AI-powered Drug Discovery, Design and Development
From BioNTech SE
Via GlobeNewswire
News headline image
Israel Based Study Shows Omicron Adapted Vaccine Shots Cut Hospitalization Rates In Elderly ↗
Israel based real-world study shows that omicron-targeted COVID-19 vaccine from Pfizer Inc (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX) reduced hospitalizations among older patients. 
Via Benzinga
News headline image
CRISPR, Genetics And AI — Why 2023 Could Be The Year For Biotech Stocks ↗
Genetic medicine is a top theme now for biotech stocks. Other trends are heating up too. 
Via Investor's Business Daily
News headline image
2 Top Biotech Stocks to Buy Right Now ↗
These two pharmaceutical companies pay market-beating dividends to shareholders. 
Via The Motley Fool
News headline image
BioNTech Announces Strategic Partnership with UK Government to Provide up to 10,000 Patients with Personalized mRNA Cancer Immunotherapies by 2030
From BioNTech SE
Via GlobeNewswire
News headline image
Valneva Touts Additional Positive Heterologous Booster Data From COVID-19 Vaccine Study ↗
 
Via Benzinga
News headline image
Why BioNTech Was a Sickly Stock This Week ↗
The world is trying hard to get past the coronavirus pandemic, and investors are trying hard to get past coronavirus stocks. 
Via The Motley Fool
News headline image
BioNTech to Present at the 41st Annual J.P. Morgan Healthcare Conference
From BioNTech SE
Via GlobeNewswire
News headline image
Three Pharma Stocks to Sell Before They Die ↗
As we head into New Year 2023, these are just some of the top pharma stocks to sell at the start of January. 
Via InvestorPlace
News headline image
BioNTech Initiates Phase 1 Clinical Trial for Malaria Vaccine Program BNT165
From BioNTech SE
Via GlobeNewswire
< Previous 1 2
...
24 25 26 27 28 29 30 31 32
...
74 75 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.